{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:27:31Z","timestamp":1787664451629,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["10438"],"award-info":[{"award-number":["10438"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010806","name":"Amgen Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018887","name":"Roche Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18696-6","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T22:38:34Z","timestamp":1763159914000},"page":"1835-1843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS\/RAF Mutated Colorectal Cancer Liver Metastases"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-5456","authenticated-orcid":false,"given":"Marinde J. G.","family":"Bond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bolhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora C.","family":"Linders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton","family":"Mijnals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remond J. A.","family":"Fijneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J. A.","family":"Punt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"18696_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ags3.12276","volume":"3","author":"K Imai","year":"2019","unstructured":"Imai K, Adam R, Baba H. How to increase the resectability of initially unresectable colorectal liver metastases: a surgical perspective. Ann Gastroenterol Surg. 2019;3:476\u201386.","journal-title":"Ann Gastroenterol Surg"},{"key":"18696_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejca.2020.09.037","volume":"141","author":"K Bolhuis","year":"2020","unstructured":"Bolhuis K, Kos M, van Oijen MGH, Swijnenburg R-J, Punt CJA. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: a systematic review. Eur J Cancer. 2020;141:225\u201338.","journal-title":"Eur J Cancer"},{"key":"18696_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0278","volume":"3","author":"G Tomasello","year":"2017","unstructured":"Tomasello G, Petrelli F, Ghidini M, Russo A, Passalacqua R, Barni S. FOLFOXIRI Plus Bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a systematic review and pooled analysis. JAMA Oncol. 2017;3:e170278.","journal-title":"JAMA Oncol"},{"key":"18696_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jjco\/hyl027","volume":"36","author":"S Takahashi","year":"2006","unstructured":"Takahashi S, Konishi M, Nakagohri T, Gotohda N, Saito N, Kinoshita T. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol. 2006;36:368\u201375.","journal-title":"Jpn J Clin Oncol"},{"key":"18696_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1245\/s10434-013-3421-8","volume":"21","author":"L Vigan\u00f2","year":"2014","unstructured":"Vigan\u00f2 L, Capussotti L, Lapointe R, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A livermetsurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21:1276\u201386.","journal-title":"Ann Surg Oncol"},{"key":"18696_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1634\/theoncologist.2015-0468","volume":"21","author":"K Imai","year":"2016","unstructured":"Imai K, Allard M-A, Benitez CC, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors? Oncologist. 2016;21:887\u201394.","journal-title":"Oncologist"},{"key":"18696_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/bjs\/znac461","volume":"110","author":"GE Wensink","year":"2023","unstructured":"Wensink GE, Bolhuis K, Elferink MAG, et al. Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases. Br J Surg. 2023;110:362\u201371.","journal-title":"Br J Surg"},{"key":"18696_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejca.2023.01.013","volume":"183","author":"K Bolhuis","year":"2023","unstructured":"Bolhuis K, Bond MJG, Amerongen MJV, et al. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: an analysis of the Dutch CAIRO5 trial. Eur J Cancer. 2023;183:49\u201359.","journal-title":"Eur J Cancer"},{"key":"18696_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/cells8060516","volume":"8","author":"F-C Bidard","year":"2019","unstructured":"Bidard F-C, Kiavue N, Ychou M, et al. Circulating tumor cells and circulating tumor DNA detection in potentially resectable metastatic colorectal cancer: a prospective ancillary study to the Unicancer Prodige-14 Trial. Cells. 2019;8:516.","journal-title":"Cells"},{"key":"18696_CR10","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.ebiom.2021.103498","volume":"70","author":"K Bolhuis","year":"2021","unstructured":"Bolhuis K, van\u2019t Erve I, Mijnals C, et al. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. EBioMedicine. 2021;70:103498.","journal-title":"EBioMedicine"},{"key":"18696_CR11","first-page":"2100101","volume":"5","author":"F Loupakis","year":"2021","unstructured":"Loupakis F, Sharma S, Derouazi M, et al. Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases. JCO Precis Oncol. 2021;5:2100101.","journal-title":"JCO Precis Oncol"},{"key":"18696_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.annonc.2024.08.2240","volume":"35","author":"K Kataoka","year":"2024","unstructured":"Kataoka K, Mori K, Nakamura Y, et al. Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY. Ann Oncol Off J Eur Soc Med Oncol. 2024;35:1015\u201325.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"18696_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(23)00219-X","volume":"24","author":"MJG Bond","year":"2023","unstructured":"Bond MJG, Bolhuis K, Loosveld OJL, et al. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group. Lancet Oncol. 2023;24:757\u201371.","journal-title":"Lancet Oncol"},{"key":"18696_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.5174","author":"MJG Bond","year":"2024","unstructured":"Bond MJG, Bolhuis K, Loosveld OJL, et al. First-line systemic treatment for initially unresectable colorectal liver metastases: post hoc analysis of the cairo5 randomized clinical trial. JAMA Oncol. 2024. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5174.","journal-title":"JAMA Oncol"},{"key":"18696_CR15","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/1878-0261.12729","volume":"14","author":"TV Henriksen","year":"2020","unstructured":"Henriksen TV, Reinert T, Christensen E, et al. The effect of surgical trauma on circulating free DNA levels in cancer patients\u2014implications for studies of circulating tumor DNA. Mol Oncol. 2020;14:1670\u20139.","journal-title":"Mol Oncol"},{"key":"18696_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","volume":"28","author":"TV Henriksen","year":"2022","unstructured":"Henriksen TV, Tarazona N, Frydendahl A, et al. Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences. Clin Cancer Res Off J Am Assoc Cancer Res. 2022;28:507\u201317.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"18696_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03579-w","author":"J Tie","year":"2025","unstructured":"Tie J, Wang Y, Lo SN, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03579-w.","journal-title":"Nat Med"},{"key":"18696_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/clinchem\/hvab040","volume":"67","author":"DCL Vessies","year":"2021","unstructured":"Vessies DCL, Linders TC, Lanfermeijer M, et al. An automated correction algorithm (ALPACA) for ddPCR data using adaptive limit of blank and correction of false positive events improves specificity of mutation detection. Clin Chem. 2021;67:959\u201367.","journal-title":"Clin Chem"},{"key":"18696_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"18696_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11605-021-05123-w","volume":"26","author":"L Vigan\u00f2","year":"2022","unstructured":"Vigan\u00f2 L, Gentile D, Galvanin J, et al. Very early recurrence after liver resection for colorectal metastases: incidence, risk factors, and prognostic impact. J Gastrointest Surg. 2022;26:570\u201382.","journal-title":"J Gastrointest Surg"},{"key":"18696_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl386","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007. https:\/\/doi.org\/10.1093\/annonc\/mdl386.","journal-title":"Ann Oncol"},{"key":"18696_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309\u201321.","journal-title":"Ann Surg"},{"key":"18696_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/bjs.10838","volume":"105","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sasaki K, Gholami S, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105:1210\u201320.","journal-title":"Br J Surg"},{"key":"18696_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jamcollsurg.2021.02.011","volume":"233","author":"MC Mason","year":"2021","unstructured":"Mason MC, Tzeng CWD, Tran Cao HS, et al. Preliminary analysis of liquid biopsy after hepatectomy for colorectal liver metastases. J Am Coll Surg. 2021;233:82.","journal-title":"J Am Coll Surg"},{"key":"18696_CR25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09449-8","author":"S Kobayashi","year":"2021","unstructured":"Kobayashi S, Nakamura Y, Taniguchi H, et al. Impact of preoperative circulating tumor DNA status on survival outcomes after hepatectomy for resectable colorectal liver metastases. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-020-09449-8.","journal-title":"Ann Surg Oncol"},{"key":"18696_CR26","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1245\/s10434-023-13362-1","volume":"30","author":"W Liu","year":"2023","unstructured":"Liu W, Jin K-M, Zhang M-H, et al. Recurrence prediction by circulating tumor DNA in the patient with colorectal liver metastases after hepatectomy: a prospective biomarker study. Ann Surg Oncol. 2023;30:4916\u201326.","journal-title":"Ann Surg Oncol"},{"key":"18696_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/SLA.0000000000005461","volume":"277","author":"TE Newhook","year":"2023","unstructured":"Newhook TE, Overman MJ, Chun YS, et al. Prospective study of perioperative circulating tumor DNA dynamics in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2023;277:813.","journal-title":"Ann Surg"},{"key":"18696_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s12072-023-10628-4","volume":"18","author":"M Liu","year":"2024","unstructured":"Liu M, Bao Q, Zhao T, et al. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Hepatol Int. 2024;18:1029\u201339.","journal-title":"Hepatol Int"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18696-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:05:26Z","timestamp":1767618326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18696-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18696"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18696-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The remaining authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURE"}},{"value":"The study was done in accordance with the standards of Good Clinical Practice and the Declaration of Helsinki. The study was approved by the medical ethical committee of the Amsterdam University Medical Centre, Amsterdam, The Netherlands. All patients provided written informed consent to study procedures before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}